Zobrazeno 1 - 10
of 206
pro vyhledávání: '"B, Lagerlöf"'
Publikováno v:
Acta Medica Scandinavica. 182:427-432
Autor:
L. E. Böttiger, B. Lagerlöf
Publikováno v:
Acta Medica Scandinavica. 165:131-135
Autor:
I. S. Trowbridge, Å. Öst, P. Reizenstein, Robert Hast, B. Christensson, Peter Biberfeld, B. Lagerlöf, R B Andreasen
Publikováno v:
Scandinavian Journal of Haematology. 34:293-302
Blood cells from 46 patients with acute myeloid leukaemia were studied for expression of various surface markers, defined by a panel of 12 monoclonal antibodies and the expression of Fc gamma receptors. Corresponding studies were done on normal bone
Autor:
Anton Platz, Johan Hansson, Inganäs M, Eva Månsson-Brahme, Stig Linder, E Lundqvist, Ulrik Ringborg, B Lagerlöf, P Sevigny
Publikováno v:
JNCI Journal of the National Cancer Institute. 89:697-702
Background: Approximately 10% of human cutaneous melanomas occur in families in which several members are affected. The familial predisposition to this disease is often associated with dysplastic nevus syndrome, a condition in which afflicted family
Publikováno v:
British Journal of Cancer
A common characteristic of cancer cells is unrestrained cell division. This may be caused by mutational changes in genes coding for components of cell cycle-controlling networks. Alterations in genes involved in G1 checkpoint control have been regist
Publikováno v:
Melanoma Research. 5:345-350
In the present study we have investigated the utility of the proliferation marker MIB 1 in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant potential. Percentages of MIB 1 immunoreactivity in the
Publikováno v:
Melanoma Research. 4:169-177
Mutations in N-ras exon 2 codon 61 were studied in formalin-fixed human melanoma metastases. DNA fragments including codon 61 were amplified by polymerase chain reaction (PCR) and mutational analysis was performed by oligonucleotide hybridization (OD
Autor:
Blomquist E, L Ostrup, B Lagerlöf, Ulrik Ringborg, G Westman, C.-M. Rudenstam, L. Hafström, Christian Ingvar, Per-Ebbe Jönsson, Christer Lindholm
Publikováno v:
Journal of Clinical Oncology. 9:2091-2094
A prospective randomized trial testing regional hyperthermic perfusion with melphalan has been conducted. Sixty-nine patients with recurrent malignant melanoma of the extremities were randomly allocated to surgery (36 patients) or surgery plus region
Publikováno v:
Cancer. 86(7)
Because the clinical and histopathologic features of vulvar melanoma had not been characterized completely in a large, homogeneous population, the authors retrospectively analyzed all such patients recorded in Sweden during a 25-year period.The Swedi
Publikováno v:
Cancer. 86(7)
In an epidemiologic study of 219 Swedish females with vulvar melanoma, the authors previously established the incidence of this disease as 0.19 per 100,000 women, with a 3% annual decrease from 1960 to 1984 and a 5-year relative survival rate of 47%.